Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 8121-8130 of 12128

Page
per page
  1. GLYX 13
    B5419 GLYX 13
    Summary: NMDA receptor partial agonist
      Soluble to 2 mg/mL
  2. Ivermectin B1a-d2
    B5812 Ivermectin B1a-d2
    Summary: Deuterated ivermectin B1a
      <43.85 mg/mL
  3. PSI-6206
    A8189 PSI-6206
     3 Citation
    Target: HCV polymerase
    Summary: Inhibitor of HCV RNA polymerase,potent and selective
      ≥13.1 mg/mL
  4. Cryptotanshinone
    N1843 Cryptotanshinone
    Summary: STAT3/AChE inhibitor
      insoluble in H2O; insoluble in EtOH; ≥4.23 mg/mL
  5. vitamin D binding protein precrusor (208-218) [Homo sapiens]/[Oryctolagus cuniculus]
    A1098 vitamin D binding protein precrusor (208-218) [Homo sapiens]/[Oryctolagus cuniculus]
    Summary: vitamin D binding protein precrusor
      ≥125.4 mg/mL
  6. (±)-J 113397
    B7119 (±)-J 113397
    Summary: NOP receptor antagonist
      <19.98 mg/mL
  7. EO 1428
    B7215 EO 1428
    Summary: p38α and p38β2 inhibitor
      Soluble in DMSO
  8. Tris DBA
    B7402 Tris DBA
    Summary: N-myristoyltransferase-1 (NMT-1) inhibitor
      <10.07 mg/mL
  9. LU AA33810
    B7427 LU AA33810
    Summary: neuropeptide Y (NPY) Y5 receptor antagonist
      <42.36 mg/mL
  10. SU 3327
    B7444 SU 3327
    Summary: JNK inhibitor
      insoluble in ethanol; <26.13 mg/mL

Items 8121-8130 of 12128

Page
per page